Molecular intercalates

The paper deals with the relations between host lattices and guest molecules. Several types of interaction of the guest molecules and the host material are explained and some conclusions are made about the arrangement of various guest molecules in the van der Waals' gap.     

N,N,N,′N′-四丁基丁二酰胺的合成及其萃取稀土离子Pr(Ⅲ)的研究

合成了四取代双酰胺萃取剂N,N,N,′N′-四丁基丁二酰胺(TBSA),并对萃取剂的结构进行了表征。研究了其萃取Pr(Ⅲ)的性能,考察了硝酸浓度、萃取剂浓度、硝酸锂浓度以及温度等对萃取分配比的影响。萃取反应在298K时,TBSA以甲苯为稀释剂时的热力学焓变为-12.83 kJ/mol。萃合物的组成结构为Pr(NO3)3.3TBSA。     

Theory and applications of ion-selective electrodes Part III

This review of ion-selective electrodes is arranged in the same way as Parts I and II. The continuous growth of the whole subject should be noted. Theory has particularly progressed through mechanistic studies. Among new types of electrodes, ISFET systems have become important. Among new applications of both solid and liquid membrane electrodes, the fluoride electrode still predominates, closely followed by potassium electrodes. In the field of biological and medical applications, the steady growth is significant. More than 800 papers published between mid-1976 and the end of 1978 are mentioned in the review.     

Potent and selective structure-based dibenzofuran inhibitors of transthyretin amyloidogenesis: kinetic stabilization of the native state

Transthyretin (TTR) amyloidogenesis requires rate-limiting tetramer dissociation and partial monomer denaturation to produce a misassembly competent species. This process has been followed by turbidity to identify transthyretin amyloidogenesis inhibitors including dibenzofuran-4,6-dicarboxylic acid (1). An X-ray cocrystal structure of TTR.1(2) reveals that it only utilizes the outer portion of the two thyroxine binding pockets to bind to and inhibit TTR amyloidogenesis. Herein, structure-based design was employed to append aryl substituents at C1 of the dibenzofuran ring to complement the unused inner portion of the thyroxine binding pockets. Twenty-eight amyloidogenesis inhibitors of increased potency and dramatically increased plasma TTR binding selectivity resulted. These function by imposing kinetic stabilization on the native tetrameric structure of TTR, creating a barrier that is insurmountable under physiological conditions. Since kinetic stabilization of the TTR native state by interallelic trans suppression is known to ameliorate disease, there is reason to be optimistic that the dibenzofuran-based inhibitors will do the same. Preventing the onset of amyloidogenesis is the most conservative strategy to intervene clinically, as it remains unclear which of the TTR misassembly intermediates results in toxicity. The exceptional binding selectivity enables these inhibitors to occupy the thyroxine binding site(s) in a complex biological fluid such as blood plasma, required for inhibition of amyloidogenesis in humans. It is now established that the dibenzofuran-based amyloidogenesis inhibitors have high selectivity, affinity, and efficacy and are thus excellent candidates for further pharmacologic evaluation.     

P-C Bond formation via direct and three-component conjugate addition catalyzed by 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD)

The direct addition of P(O)-H bonds (dialkyl phosphites and diphenyl phosphonite) across various activated alkenes was catalyzed effectively by 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD). This is a mild, rapid and efficient protocol to generate P-C bonds. This simple procedure allows a series of dialkyl alkylphosphonates and trisubstituted phosphine oxides to be prepared in high yields. Further investigation resulted in a convenient one-pot, three-component reaction containing diphenyl phosphonite, malononitrile and an aldehyde.